Matches in SemOpenAlex for { <https://semopenalex.org/work/W1601595912> ?p ?o ?g. }
- W1601595912 abstract "Bacterial vaginosis is an imbalance of the normal vaginal flora with an overgrowth of anaerobic bacteria and a lack of the normal lactobacillary flora. Women may have symptoms of a characteristic vaginal discharge but are often asymptomatic. Bacterial vaginosis during pregnancy has been associated with poor perinatal outcomes and, in particular, preterm birth (PTB). Identification and treatment may reduce the risk of PTB and its consequences.To assess the effects of antibiotic treatment of bacterial vaginosis in pregnancy.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2012), searched cited references from retrieved articles and reviewed abstracts, letters to the editor and editorials.Randomised trials comparing antibiotic treatment with placebo or no treatment, or comparing two or more antibiotic regimens in pregnant women with bacterial vaginosis or intermediate vaginal flora whether symptomatic or asymptomatic and detected through screening.Two review authors independently assessed trials for inclusion, trial quality and extracted data. We contacted study authors for additional information.We included 21 trials of good quality, involving 7847 women diagnosed with bacterial vaginosis or intermediate vaginal flora.Antibiotic therapy was shown to be effective at eradicating bacterial vaginosis during pregnancy (average risk ratio (RR) 0.42; 95% confidence interval (CI) 0.31 to 0.56; 10 trials, 4403 women; random-effects, T² = 0.19, I² = 91%). Antibiotic treatment also reduced the risk of late miscarriage (RR 0.20; 95% CI 0.05 to 0.76; two trials, 1270 women, fixed-effect, I² = 0%).Treatment did not reduce the risk of PTB before 37 weeks (average RR 0.88; 95% CI 0.71 to 1.09; 13 trials, 6491 women; random-effects, T² = 0.06, I² = 48%), or the risk of preterm prelabour rupture of membranes (RR 0.74; 95% CI 0.30 to 1.84; two trials, 493 women). It did increase the risk of side-effects sufficient to stop or change treatment (RR 1.66; 95% CI 1.02 to 2.68; four trials, 2323 women, fixed-effect, I² = 0%).In this updated review, treatment before 20 weeks' gestation did not reduce the risk of PTB less than 37 weeks (average RR 0.85; 95% CI 0.62 to 1.17; five trials, 4088 women; random-effects, T² = 0.06, I² = 49%).In women with a previous PTB, treatment did not affect the risk of subsequent PTB (average RR 0.78; 95% CI 0.42 to 1.48; three trials, 421 women; random-effects, T² = 0.19, I² = 72%).In women with abnormal vaginal flora (intermediate flora or bacterial vaginosis), treatment may reduce the risk of PTB before 37 weeks (RR 0.53; 95% CI 0.34 to 0.84; two trials, 894 women).One small trial of 156 women compared metronidazole and clindamycin, both oral and vaginal, with no significant differences seen for any of the pre-specified primary outcomes. Statistically significant differences were seen for the outcomes of prolongation of gestational age (days) (mean difference (MD) 1.00; 95% CI 0.26 to 1.74) and birthweight (grams) (MD 75.18; 95% CI 25.37 to 124.99) however these represent relatively small differences in the clinical setting.Oral antibiotics versus vaginal antibiotics did not reduce the risk of PTB (RR 1.09; 95% CI 0.78 to 1.52; two trials, 264 women). Oral antibiotics had some advantage over vaginal antibiotics (whether metronidazole or clindamycin) with respect to admission to neonatal unit (RR 0.63; 95% CI 0.42 to 0.92, one trial, 156 women), prolongation of gestational age (days) (MD 9.00; 95% CI 8.20 to 9.80; one trial, 156 women) and birthweight (grams) (MD 342.13; 95% CI 293.04 to 391.22; one trial, 156 women).Different frequency of dosing of antibiotics was assessed in one small trial and showed no significant difference for any outcome assessed.Antibiotic treatment can eradicate bacterial vaginosis in pregnancy. The overall risk of PTB was not significantly reduced. This review provides little evidence that screening and treating all pregnant women with bacterial vaginosis will prevent PTB and its consequences. When screening criteria were broadened to include women with abnormal flora there was a 47% reduction in preterm birth, however this is limited to two included studies." @default.
- W1601595912 created "2016-06-24" @default.
- W1601595912 creator A5003891238 @default.
- W1601595912 creator A5037509074 @default.
- W1601595912 creator A5045743294 @default.
- W1601595912 creator A5084703885 @default.
- W1601595912 date "2013-01-31" @default.
- W1601595912 modified "2023-10-01" @default.
- W1601595912 title "Antibiotics for treating bacterial vaginosis in pregnancy" @default.
- W1601595912 cites W128344309 @default.
- W1601595912 cites W1495654502 @default.
- W1601595912 cites W1511490662 @default.
- W1601595912 cites W1526092128 @default.
- W1601595912 cites W1547913490 @default.
- W1601595912 cites W1601595912 @default.
- W1601595912 cites W1636497156 @default.
- W1601595912 cites W178415459 @default.
- W1601595912 cites W1816290939 @default.
- W1601595912 cites W1868667984 @default.
- W1601595912 cites W1963808164 @default.
- W1601595912 cites W1966546381 @default.
- W1601595912 cites W1968292692 @default.
- W1601595912 cites W1971502646 @default.
- W1601595912 cites W1971645220 @default.
- W1601595912 cites W1978526246 @default.
- W1601595912 cites W1984895921 @default.
- W1601595912 cites W1985289222 @default.
- W1601595912 cites W1985659402 @default.
- W1601595912 cites W1987041143 @default.
- W1601595912 cites W1991880863 @default.
- W1601595912 cites W1998861228 @default.
- W1601595912 cites W2000487319 @default.
- W1601595912 cites W2002144401 @default.
- W1601595912 cites W2004783933 @default.
- W1601595912 cites W2009513770 @default.
- W1601595912 cites W2011692789 @default.
- W1601595912 cites W2011872379 @default.
- W1601595912 cites W2013284596 @default.
- W1601595912 cites W2016377041 @default.
- W1601595912 cites W2020044680 @default.
- W1601595912 cites W2022832304 @default.
- W1601595912 cites W2023237612 @default.
- W1601595912 cites W2024170846 @default.
- W1601595912 cites W2025511858 @default.
- W1601595912 cites W2026790157 @default.
- W1601595912 cites W2034972935 @default.
- W1601595912 cites W2043814908 @default.
- W1601595912 cites W2051155346 @default.
- W1601595912 cites W2051544694 @default.
- W1601595912 cites W2051973119 @default.
- W1601595912 cites W2054342635 @default.
- W1601595912 cites W2057373894 @default.
- W1601595912 cites W2060858779 @default.
- W1601595912 cites W2064744048 @default.
- W1601595912 cites W2069251121 @default.
- W1601595912 cites W2071816179 @default.
- W1601595912 cites W2073807290 @default.
- W1601595912 cites W2077919336 @default.
- W1601595912 cites W2078797436 @default.
- W1601595912 cites W2081329471 @default.
- W1601595912 cites W2083122102 @default.
- W1601595912 cites W2086680517 @default.
- W1601595912 cites W2094387016 @default.
- W1601595912 cites W2100576440 @default.
- W1601595912 cites W2120035518 @default.
- W1601595912 cites W2121260206 @default.
- W1601595912 cites W2123455772 @default.
- W1601595912 cites W2142079607 @default.
- W1601595912 cites W2154296030 @default.
- W1601595912 cites W2155703638 @default.
- W1601595912 cites W2161712363 @default.
- W1601595912 cites W2167742601 @default.
- W1601595912 cites W2317599024 @default.
- W1601595912 cites W2317894502 @default.
- W1601595912 cites W2322463613 @default.
- W1601595912 cites W2323992983 @default.
- W1601595912 cites W2328487449 @default.
- W1601595912 cites W4210790265 @default.
- W1601595912 cites W4230447751 @default.
- W1601595912 cites W4231769684 @default.
- W1601595912 cites W4234481586 @default.
- W1601595912 cites W4237414001 @default.
- W1601595912 cites W4238679199 @default.
- W1601595912 cites W4240182045 @default.
- W1601595912 cites W4246536314 @default.
- W1601595912 cites W4249976463 @default.
- W1601595912 cites W4376849391 @default.
- W1601595912 cites W87927868 @default.
- W1601595912 doi "https://doi.org/10.1002/14651858.cd000262.pub4" @default.
- W1601595912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4164464" @default.
- W1601595912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23440777" @default.
- W1601595912 hasPublicationYear "2013" @default.
- W1601595912 type Work @default.
- W1601595912 sameAs 1601595912 @default.
- W1601595912 citedByCount "286" @default.
- W1601595912 countsByYear W16015959122012 @default.
- W1601595912 countsByYear W16015959122013 @default.
- W1601595912 countsByYear W16015959122014 @default.
- W1601595912 countsByYear W16015959122015 @default.
- W1601595912 countsByYear W16015959122016 @default.